STOCK TITAN

Syneos Health (SYNH) Stock News, Apr-Jul 2023

SYNH NASDAQ
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
partnership
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.84%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.84%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
management
-
Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) has announced the release of its first quarter 2023 financial results, scheduled for May 10, 2023. The earnings call will commence at 8:00 a.m. ET, and interested investors can access the live webcast through the Investor Relations section of their website.

Participants are required to register in advance to receive a confirmation email with dial-in instructions and a unique passcode. A replay of the webcast will be accessible on the website after 1:00 p.m. ET on the same day.

Syneos Health is recognized as a leading fully integrated biopharmaceutical solutions organization, focusing on translating clinical and commercial insights into improved patient outcomes across over 110 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
none